Which Big Pharma CEOs Least Deserved Their Big Pay Increases?

...rsky didn't get a salary bump at all last year, although he certainly wasn't hurting, raking in $1.6 million. Bristol-Myers Squibb CEO Giovanni Caforio and Gilead Sciences CEO John Milligan enjoyed the heftiest pay raise...
Read Full Article